218 related articles for article (PubMed ID: 7869670)
1. Varied value of urinary N-acetyl-beta-D-glucosaminidase isoenzyme B in males of reproductive age.
Itoh Y; Numata Y; Morita A; Asano Y; Kawai T
Kidney Int Suppl; 1994 Nov; 47():S38-42. PubMed ID: 7869670
[TBL] [Abstract][Full Text] [Related]
2. [N-acetyl-beta-D-glucosaminidase].
Furuhata N; Shiba K; Nara N
Nihon Rinsho; 1995 May; 53(5):1267-76. PubMed ID: 7602790
[TBL] [Abstract][Full Text] [Related]
3. [An important variability factor in determination of urinary activity of N-acetyl-beta-D-glucosaminidase: contamination of urine with semen].
Pastoris A; Artioli D; Catalani S; Alinovi R; Sbaffi A; Mutti A; Apostoli P
Med Lav; 2004; 95(3):180-5. PubMed ID: 15293374
[TBL] [Abstract][Full Text] [Related]
4. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
[TBL] [Abstract][Full Text] [Related]
5. [Studies of enzymuria and proteinuria: Report 1: N-acetyl-beta-glucosaminidase in urological diseases].
Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kakinoki K; Kawashima H; Yoshimura R; Umeda M; Maekawa T
Hinyokika Kiyo; 1987 Jun; 33(6):807-11. PubMed ID: 2445186
[TBL] [Abstract][Full Text] [Related]
6. [Comparison of urinary and seminal N-acetyl-beta-glucosaminidase isoenzymes].
Yasumoto R; Asakawa M; Yamamoto M; Doi Y; Kawashima H; Umeda M; Tanabe S; Nishisaka N; Kakinoki K; Maekawa M
Hinyokika Kiyo; 1987 Nov; 33(11):1827-9. PubMed ID: 3445866
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme activities in the urine of children with primary and secondary hypertension].
Zoch-Zwierz W; Winiecka W; Tomaszewska B; Wierciński R
Wiad Lek; 1992 Jul; 45(13-14):498-502. PubMed ID: 1462566
[TBL] [Abstract][Full Text] [Related]
8. [Urinary excretion of N-acetyl-beta-D-glucosaminidase (NAG) and its isoenzyme B as a marker of the nephrotoxicity of gentamicin: re-test from an animal model].
Ali-Miraftab H; Bourbouze R; Bondiou MT; Percheron F
Pathol Biol (Paris); 1988 Mar; 36(3):240-4. PubMed ID: 3283687
[TBL] [Abstract][Full Text] [Related]
9. Expression modes of urinary N-acetyl-beta-D-glucosaminidase in patients with chronic renal insufficiency.
Tassi C; Mancuso F; Feligioni L; Marangi M; Capodicasa E
Clin Chim Acta; 2004 Aug; 346(2):129-33. PubMed ID: 15256313
[TBL] [Abstract][Full Text] [Related]
10. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
[TBL] [Abstract][Full Text] [Related]
11. [An early and specific indicator of aminoglycoside nephrotoxicity: isoenzyme B of urinary N-acetyl-beta-D-glucosaminidase (NAG)].
Gibey R; Dupond JL; Peltier H; Iehl-Robert M; Henry JC
Pathol Biol (Paris); 1986 May; 34(5):342-5. PubMed ID: 3534703
[TBL] [Abstract][Full Text] [Related]
12. The role of NAG (N-acetyl-beta-D-glucosaminidase) in the diagnosis of kidney disease including the monitoring of nephrotoxicity.
Price RG
Clin Nephrol; 1992; 38 Suppl 1():S14-9. PubMed ID: 1295704
[TBL] [Abstract][Full Text] [Related]
13. [Urinary N-acetyl-beta-D-glucosaminidase and its isoenzymes in smoking and non-smoking workers at copper foundry occupational co-exposed to arsenic cadmium and lead].
Milnerowicz H; Bizoń A; Witt K; Antonowicz-Juchniewicz J; Andrzejak R
Przegl Lek; 2008; 65(10):518-21. PubMed ID: 19189537
[TBL] [Abstract][Full Text] [Related]
14. The possibility of determining N-acetyl-beta-D-glucosaminidase isoenzymes under alkaline conditions.
Mandić LM; Aćimović JM; Jovanović VB
Clin Biochem; 2005 Apr; 38(4):384-9. PubMed ID: 15766740
[TBL] [Abstract][Full Text] [Related]
15. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
[TBL] [Abstract][Full Text] [Related]
16. N-acetyl-beta-D-glucosaminidase (NAG) as the most sensitive marker of tubular dysfunction for monitoring residents in non-polluted areas.
Moriguchi J; Inoue Y; Kamiyama S; Horiguchi M; Murata K; Sakuragi S; Fukui Y; Ohashi F; Ikeda M
Toxicol Lett; 2009 Oct; 190(1):1-8. PubMed ID: 19467302
[TBL] [Abstract][Full Text] [Related]
17. Stabilities of N-acetyl-beta-D-glucosaminidase (NAG) isoenzymes in urine: advantage of NAG isoenzyme B measurement in clinical applications.
Morita A; Numata Y; Kosugi Y; Noto A; Takeuchi N; Uchida K
Clin Chim Acta; 1998 Nov; 278(1):35-43. PubMed ID: 9877122
[TBL] [Abstract][Full Text] [Related]
18. Measurement of N-acetyl-beta-glucosaminidase and its isoenzymes in urine methods and clinical applications.
Price RG
Eur J Clin Chem Clin Biochem; 1992 Oct; 30(10):693-705. PubMed ID: 1493161
[TBL] [Abstract][Full Text] [Related]
19. [NAG (N-acetyl-beta-D-glucosaminidase)--a sensitive marker for disorders of kidney function].
Skrezek C; Bertermann H; Schulz FP; König B
Urologe A; 1990 Jan; 29(1):27-31. PubMed ID: 2316078
[TBL] [Abstract][Full Text] [Related]
20. Measurement of urinary N-acetyl-b-D-glucosaminidase in adult patients with cystic fibrosis: before, during and after treatment with intravenous antibiotics.
Etherington C; Bosomworth M; Clifton I; Peckham DG; Conway SP
J Cyst Fibros; 2007 Jan; 6(1):67-73. PubMed ID: 16844430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
